(1)
[Budget Impact Analysis of Delayed-Release Dimethyl-Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy]. FE 2016, 17 (1), 29-39. https://doi.org/10.7175/fe.v17i1.1237.